Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Endocrine-Related Cancer is Scopus-indexed (Q1, CiteScore 7.2), WoS SCIE. Published by BioScientifica Ltd..
Checked against the index lists dated .
ISSN 1351-0088Verify ISSN ↗1479-6821Verify ISSN ↗
Publisher: BioScientifica Ltd.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 83 / 428 | 80th | Q1 |
| Endocrinology, Diabetes and Metabolism | 59 / 250 | 76th | Q1 |
| Endocrinology | 37 / 132 | 72nd | Q2 |
| Cancer Research | 74 / 233 | 68th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1994–present, best quartile Q1, CiteScore 7.2.
Endocrine-Related Cancer is Q1 in Oncology (rank 83 of 428), Q1 in Endocrinology, Diabetes and Metabolism (rank 59 of 250) and Q2 in Endocrinology (rank 37 of 132), by CiteScore 2025. It is ranked in 4 subject areas in all.
Endocrine-Related Cancer is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7.2, which places it in quartile Q1 at the 80th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.544, quartile Q1, with an H-index of 154.
Endocrine-Related Cancer is published by BioScientifica Ltd. Its print ISSN is 1351-0088 and its online ISSN is 1479-6821.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Endocrine-Related Cancer has an h-index of 173 and a 2-year mean of 2.63 citations per paper (OpenAlex). Its Scopus CiteScore is 7.2, quartile Q1. On 2-year citations it ranks #141 of 424 Scopus journals in Oncology.
Endocrine-Related Cancer published 120 papers in 2025; its busiest recent year was 2018 with 152. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 59 research articles (2026), authors are most often from China (18.6%), United States (15.1%) and United Kingdom (13.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 4 retracted papers are recorded (1.4 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.